A B S T R A C T Recently, evidence has been reported to suggest that human platelets like several other circulating blood cells may bind insulin. To examine whether human platelets contain specific insulin receptors, washed human platelets suspended in Hepes buffer were incubated at 24°C with 1251-insulin in the presence and absence of unlabeled insulin and specific insulin binding was determined. Insulin binding by platelets increased progressively with time of incubation to reach a maximum at 3 h and was proportional to the number of platelets in the incubation mixture. Maximum insulin binding was observed at pH 8. Insulin degradation by platelets as assessed by TCA precipitability and reincubation studies was minimal. Scatchard analysis ofthe binding data and dissociation studies revealed evidence of negative cooperativity of the platelet insulin receptor. A high affinity dissociation constant of _3 x 109 M-1 was determined and the concentration of platelet insulin receptors was estimated as 25 binding sites/,un2 platelet surface area. Binding of 1251-insulin by platelets was inhibited by unlabeled porcine insulin and to a lesser extent by catfish insulin and porcine proinsulin but not by glucagon, prolactin, growth hormone, and thrombin. The findings indicate that human platelets contain specific insulin receptors. The significance of the platelet insulin receptor, particularly with respect to altered platelet function in diabetes mellitus, remains to be determined.
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INTRODUCTION
There is evidence that a number of different cells contain specific insulin receptors, including certain formed elements of the circulating blood such a monocytes (1, 2) , lymphocytes (3) , and erythrocytes (4) (5) (6) . Recently, Beck-Nielsen et al. (2) Preparation of platelet suspensions. Blood was collected from healthy male and female volunteers by clean venipuncture and two-syringe technique into a one-seventh volume of acid citrate dextrose solution. Written informed consent was obtained from all subjects before blood collection. Platelets were isolated by differential centrifugation according to the method of Mustard et al. (7) and resuspended in Tyrode's solution containing 0.35% bovine serum albumin (Sigma Chemical Co., St. Louis, Mo.) and potato apyrase (prepared as described [8] ) (3 U/ml). The platelet suspension was again centrifuged at 2,500 g for 10 min and the sedimented platelets were resuspended in Hepes buffer (0.1 M Hepes, 0.12 M NaCl, 1.2 mM MgSO4, 2.5 mM KCl, 10 mM glucose, 1 mM EDTA, 1% bovine serum albumin), pH 8.0. Leukocyte contamination was monitored by phase-contrast microscopy (9) and found to be one leukocyte or less per 100,000 platelets. The final platelet suspensions were stored in plastic tubes at room temperature.
Platelet size estimation. Mean platelet volume was determined after appropriate dilution of aliquots of the final platelet suspensions with isotonic saline using a Coulter I Abbreviation used in this paper: DIP, diisopropyl flurophosphate. model H4 channelyzer (Coulter Electronics Inc., Hialeah, Fla.) (without hydrodynamic focussing) as described (10) .
Insulin binding assay. Porcine insulin was iodinated by a modification of the chloramine T procedure (11) . The specific activity ofthe biologically active material was 120-300 ,uCi/,ug (0.4-0.5 iodine atoms per insulin molecule). The labeled insulin was purified by Sephadex G-50 chromatography (Pharmacia Fine Chemicals, Piscataway, N. J.) and was used within two wk of preparation. 1251-insulin (120-650 pg/ml) was added to suspensions of platelets in Hepes buffer (0.5-2.0 x 106/p.l) at pH 8.0, unless stated otherwise, in the presence or absence of unlabeled insulin (0-10 ,ug/ml). The mixtures were incubated at 24°C. At various time intervals 0.5-ml aliquots of the mixtures were transferred to plastic tubes containing 0.5 ml Hepes buffer (4°C) and immediately centrifuged for with the platelets in the presence of 10 Zg/ml of unlabeled insulin from the total counts per minute determined in the platelet sediments in the absence of unlabeled hormone. In some experiments binding of 1251-insulin was studied in the presence of either unlabeled insulin or porcine proinsulin, catfish insulin, glucagon, growth hormone, or DIP thrombin.
RESULTS
The time-course of binding of 125I-insulin by platelets in the absence of unlabeled insulin (total insulin binding) and presence of excess unlabeled insulin (nonspecific binding) is illustrated in Fig. 1 . Total insulin binding increased progressively to reach a maximum between 2 and 3 h of incubation. Half-maximum binding was observed at 30 min. Nonspecific insulin binding was 10-15% of total binding and remained relatively constant throughout the incubation period. All binding experiments were performed at pH 8.0 because that pH yielded maximum specific binding. Insulin degradation in the medium by platelets was studied by both TCA precipitability and rebinding of the labeled hormone after incubation with platelets for 3 h and was found to be negligible (results not shown).
The amount of 1251-insulin bound to platelets during a 3-h incubation period was found to be directly proportional to the concentration ofplatelets in the incubation mixture (Fig. 2) .
The specific binding of 125I-insulin tended toward saturation when increasing amounts of radioiodinated insulin were added to platelets (Fig. 3) . However, complete saturation was not observed in this and one other experiment (not shown) at free 1251-insulin concentrations of up to 7 pmol/ml, the maximum concentration readily attainable with 1251-insulin. Similar results, i.e., lack of saturation, have been reported for insulin binding to fat cells (12) . For this reason studies were conducted using more traditional competitive binding techniques, with a fixed concentration of 1251-insulin and increasing concentrations of unlabeled hormone.
There was a progressive decrease in the amount of '251-insulin bound to the platelets with increasing concentrations of unlabeled hormone in the medium (Fig.  4) . Half-maximum displacement of '251-insulin was observed at 3.5 ng/ml of unlabeled insulin.
A Scatchard (13) insulin in the presence of excess unlabeled hormone, after the model of negative cooperativity proposed by
De Meyts et al. (14) . To further test for negative cooperativity ofthe platelet insulin receptor, the dissociation of 1251-insulin bound to platelets was studied in the absence and presence of excess unlabeled hormone. Platelets were incubated with 1251-insulin in the presence and absence ofunlabeled insulin (10 gg/ml) for 3 h and specific binding was determined. The platelets were then sedimented at 2,000 g for 10 min and resuspended in Hepes buffer with or without the addition of unlabeled insulin (1 ,ug/ml). The mixtures were incubated at 24°C. Aliquots (0.5 ml) were removed at certain time intervals and 1251-insulin binding was determined and expressed as percentage ofthat observed at the end of the initial 3-h incubation period. The results shown in Fig. 6 indicate that the rate of dissociation of 125I-insulin is enhanced in the presence of unlabeled insulin. The specificity of the platelet insulin receptor was defined further by experiments in which the displacement of 1251-insulin by unlabeled porcine insulin (100 ng/nl) was compared with that induced by unlabeled porcine proinsulin, catfish insulin, and several other unrelated peptides. The data shown in Table I indicate that catfish insulin and porcine proinsulin, both of which are less biologically active than porcine insulin (3, 15) , are also less able to displace 125I-insulin from the platelet receptor. Neither glucagon, prolactin, growth hormone, nor DIP thrombin caused measurable displacement of 125I-insulin.
The mean concentration of insulin-binding sites in human platelets estimated from the x-intercept of the Scatchard plots of four experiments was 570+100 (SD) per platelet. This concentration is appreciably less than that reported for some of the other insulin-binding cells such as cultured human lymphocytes (16) , human (6, 17) and turkey (5) erythrocytes, and rat adipocytes (Table II) .
DISCUSSION
The data presented in this paper indicate that human platelets contain binding sites for insulin as suggested by the work of others (2) . Although the platelet suspensions used in this study were not entirely free of leukocytes, it seems highly unlikely that leukocyte contamination of the platelet preparations could account for a significant portion of the insulin binding observed. The results of competitive binding studies Human platelet (this study) 570 25 Human lymphocyte (12, 18) 12,500 20 Human erythrocyte (13, 14) 2,000
14
Turkey erythrocyte (15) 3,000 29 Rat adipocyte (16) 170,000 23 The numbers in parentheses indicate references.
indicate that binding of 1251-insulin occurs at physiologic concentrations (Fig. 4) and illustrate the specific nature of the platelet insulin receptor (Table I) . Thus, unlabeled porcine insulin and to a lesser extent the biologically less active catfish insulin and porcine proinsulin were able to displace '251-insulin, whereas no displacement was observed with glucagon, prolactin, growth hormone, and DIP thrombin. The failure of DIP thrombin to displace labeled insulin from platelets is of particular interest because the presence of specific thrombin receptors in human platelets has been demonstrated (19) and insulin does not inhibit binding of DIP thrombin by human platelets.2 Certain properties of the human platelet insulin receptor defined in this study, such as alkaline pH-optimum, high affinity binding constant, and curvilinear Scatchard plot, were found to closely resemble those described for other insulin binding cells (2-6, 16-18, 20, 21) . The results of the Scatchard analysis of the data from the competitive binding studies appear to be consistent with the presence of several classes of insulin binding sites with different affinities. However, the data can also be interpreted as indicating a single population of insulin receptors exhibiting negative cooperativity with increasing occupancy of receptors (14) . Indeed, our finding of enhanced dissociation of 125I_ insulin from platelets in the presence of unlabeled insulin seems to support the possibility of negative cooperativity of the platelet insulin receptor (14, 22) . However, the interpretation of enhanced dissociation ofbound labeled ligand with increasing concentrations of unlabeled ligand in the medium as indicating negative cooperativity has recently been questioned (23) . In this study (23) , the dissociation rate of 125I-insulin bound to cultured human lymphocytes appeared to be virtually independent of receptor occupancy.
It is possible that a portion of the platelet-associated 1251-insulin reflects uptake of specifically bound insulin bound by the platelet. This is likely if one considers the relatively long period of incubation required for insulin binding to reach steady state (Fig. 1) , and the finding that a significant portion of the labeled insulin did not dissociate from the platelets (Fig. 6) . One would expect such a finding because at the temperature at which the experiments were carried out (24'C) uptake may still occur but intracellular degradation might be suppressed leading to a build-up of intemalized insulin. This is consistent with recent observations demonstrating an uptake or compartmentalization of specifically bound insulin by IM9-lymphocytes (24), hepatocytes (25) , and adipocytes (26) .
The concentration of insulin receptors per platelet in this study was found to be substantially less than Dissociation of bound 125I-insulin from the platelets in the presence and absence ofunlabeled insulin. Aliquots of a platelet suspension (680,000/1l) were incubated with 1251-insulin (382 pg/ml) in the presence and absence of unlabeled insulin (10,ug/ml) at 24°C for 3 h and specific insulin binding was determined. The platelets were then resuspended in Hepes buffer containing no unlabeled insulin (0) or containing 1 ,Lg/ml of unlabeled insulin (0). The mixtures were incubated at 24°C and duplicate 0.5-ml aliquots were removed at certain time intervals for determination of specific platelet-associated radioactivity. The results are expressed as percentage of the total specific binding (1.3%) determined at the end of the initial 3-h incubation period.
that reported for other cells, a finding that could be readily explained by the comparably small size of the platelet. Indeed, the concentration of insulin receptors per platelet unit surface area appeared to be remarkably similar to that described for other cells. However, the calculation of the platelet unit surface area was based on the assumption of a smooth, continuous outer cell surface. Because intact disk-shaped platelets, as used in this study, appear to have an extensive sponge-like, internal, surface-connecting, canalicular system (27) , the actual surface area of the platelet potentially accessible for insulin binding is probably much greater as indicated by the work of others (28) . Thus, the concentration of insulin receptors per platelet unit surface area may have been grossly overestimated. However, this error is also inherent to a variable extent in previous estimations of insulin receptors in other cells that have irregular surfaces.
The biological significance of the platelet insulin receptor demonstrated in our study is not clear. There is some evidence that insulin may affect platelet energy metabolism. Thus, insulin was found to increase lactate formation by human platelets in the presence ofglucose (29) . However, the concentrations of insulin used in this study (0.004-0.4 U/ml) were far in excess ofplasma insulin concentrations observed in man, leaving the significance of this finding in doubt. In addition, potentiation of glucose-induced inhibition of collageninduced platelet aggregation in citrated human plateletrich plasma has been reported (30) . However, in this in vitro study a commercial insulin preparation was used and the possible effects of contaminants and the preservative contained in this preparation were not investigated. Inhibition of ADP-and calcium-induced platelet aggregation in citrated platelet-rich plasma from diabetic patients after intravenous injection of insulin has also been reported (31) , but this finding was quite inconsistent. Accumulating evidence from a number of laboratories (31) (32) (33) (34) 
